Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Masotti

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
ESC Heart Failure|November 20, 2020
Renin profiling predicts neurohormonal response to sacubitril/valsartanGiuseppe Vergaro, Paolo Sciarrone, Concetta Prontera, et al.
Giornale Italiano Di Cardiologia (2006)|May 7, 2021
[Biomarkers for the diagnosis and management of heart failure: new frontiers]Giuseppe Vergaro, Vincenzo Castiglione, Alberto Aimo, et al.
European Journal of Applied Physiology|December 20, 2017
Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjectsCristina Vassalle, Silvia Masotti, Valter Lubrano, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|May 27, 2014
Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist deviceTommaso Prescimone, Silvia Masotti, Andrea D'Amico, et al.
International Journal of Cardiology|May 21, 2021
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failureGiuseppe Vergaro, Alberto Aimo, Ester Taurino, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 10, 2015
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC)Antonio Fortunato, Concetta Prontera, Silvia Masotti, et al.
Giornale Italiano Di Cardiologia (2006)|March 30, 2021
[Biomarkers for the diagnosis and management of heart failure: natriuretic peptides]Vincenzo Castiglione, Giuseppe Vergaro, Alberto Aimo, et al.
Advances in Clinical Chemistry|October 28, 2019
Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: From theory to practiceAldo Clerico, Martina Zaninotto, Andrea Padoan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 25, 2018
Time-course of circulating cardiac and inflammatory biomarkers after Ventricular Assist Device implantation: Comparison between paediatric and adult patientsRosetta Ragusa, Concetta Prontera, Arianna Di Molfetta, et al.
BMC Cardiovascular Disorders|September 1, 2023
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fractionGiuseppe Vergaro, Annamaria Del Franco, Alberto Aimo, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
ESC Heart Failure|November 20, 2020
Renin profiling predicts neurohormonal response to sacubitril/valsartanGiuseppe Vergaro, Paolo Sciarrone, Concetta Prontera, et al.
Giornale Italiano Di Cardiologia (2006)|May 7, 2021
[Biomarkers for the diagnosis and management of heart failure: new frontiers]Giuseppe Vergaro, Vincenzo Castiglione, Alberto Aimo, et al.
European Journal of Applied Physiology|December 20, 2017
Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjectsCristina Vassalle, Silvia Masotti, Valter Lubrano, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|May 27, 2014
Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist deviceTommaso Prescimone, Silvia Masotti, Andrea D'Amico, et al.
International Journal of Cardiology|May 21, 2021
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failureGiuseppe Vergaro, Alberto Aimo, Ester Taurino, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 10, 2015
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC)Antonio Fortunato, Concetta Prontera, Silvia Masotti, et al.
Giornale Italiano Di Cardiologia (2006)|March 30, 2021
[Biomarkers for the diagnosis and management of heart failure: natriuretic peptides]Vincenzo Castiglione, Giuseppe Vergaro, Alberto Aimo, et al.
Advances in Clinical Chemistry|October 28, 2019
Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: From theory to practiceAldo Clerico, Martina Zaninotto, Andrea Padoan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 25, 2018
Time-course of circulating cardiac and inflammatory biomarkers after Ventricular Assist Device implantation: Comparison between paediatric and adult patientsRosetta Ragusa, Concetta Prontera, Arianna Di Molfetta, et al.
BMC Cardiovascular Disorders|September 1, 2023
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fractionGiuseppe Vergaro, Annamaria Del Franco, Alberto Aimo, et al.
Pageof 4